NMDA receptor regulation of levodopa-induced behavior and changes in striatal G protein-coupled receptor kinase 6 and ß-arrestin-1 expression in parkinsonian rats

NMDA receptor regulation of levodopa-induced behavior and changes in striatal G protein-coupled receptor kinase 6 and ß-arrestin-1 expression in parkinsonian rats

Na Wu, Lu Song, Xinxin Yang, Weien Yuan, Zhenguo Liu Department of Neurology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China Background: Parkinson’s disease is a neurodegenerative disorder caused by loss of dopaminergic ne...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wu N, Song L, Yang X, Yuan W, Liu Z
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
AIM
dopamine
6-hydroxydopamine
L-DOPA
LID
GRK6
GPCR
dyskinesia
nigra
Geriatrics
RC952-954.6
Acceso en línea:https://doaj.org/article/d603fff1d73e4a34942f355af17d38d8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d603fff1d73e4a34942f355af17d38d8
record_format dspace
spelling oai:doaj.org-article:d603fff1d73e4a34942f355af17d38d82021-12-02T08:46:00ZNMDA receptor regulation of levodopa-induced behavior and changes in striatal G protein-coupled receptor kinase 6 and ß-arrestin-1 expression in parkinsonian rats1178-1998https://doaj.org/article/d603fff1d73e4a34942f355af17d38d82013-03-01T00:00:00Zhttps://www.dovepress.com/nmda-receptor-regulation-of-levodopa-induced-behavior-and-changes-in-s-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Na Wu, Lu Song, Xinxin Yang, Weien Yuan, Zhenguo Liu Department of Neurology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China Background: Parkinson’s disease is a neurodegenerative disorder caused by loss of dopaminergic neurons in the substantia nigra. The dopamine precursor, levodopa, remains the most effective and common treatment for this disorder. However, long-term administration of levodopa is known to induce characteristic dyskinesia, and molecular mechanisms underlying dyskinesia are poorly understood. Methods: In this study, we investigated the effect of 6-hydroxydopamine lesions in dopaminergic neurons and chronic treatment with levodopa on expression of G protein-coupled receptor kinase 6 and ß-arrestin-1, two key regulators of G protein-coupled receptors, in the rat striatum. Results: We found that a unilateral 6-hydroxydopamine lesion reduced expression of G protein-coupled receptor kinase 6 and ß-arrestin-1 protein in the lesioned striatum. Reduction of these two proteins persisted in 6-hydroxydopamine-lesioned rats on chronic levodopa treatment for 23 days. In addition, coadministration of the N-methyl-D-aspartate receptor antagonist, MK-801, and levodopa reversed the reduction of G protein-coupled receptor kinase 6 and ß-arrestin-1 in the striatum. MK-801 also attenuated levodopa-induced dyskinetic behavior. Conclusion: These data indicate that G protein-coupled receptor kinase 6 and ß-arrestin-1 in striatal neurons are sensitive to dopamine depletion and are downregulated in rats with Parkinson’s disease and in levodopa-treated rats with the disease. This downregulation seems to require activation of N-methyl-D-aspartate glutamate receptors. Keywords: dopamine, levodopa, levodopa-induced dyskinesias, G protein-coupled receptors, G protein-coupled receptor kinase dyskinesiaWu NSong LYang XYuan WLiu ZDove Medical PressarticleAIMdopamine6-hydroxydopamineL-DOPALIDGRK6GPCRdyskinesianigraGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 8, Pp 347-352 (2013)
institution DOAJ
collection DOAJ
language EN
topic AIM
dopamine
6-hydroxydopamine
L-DOPA
LID
GRK6
GPCR
dyskinesia
nigra
Geriatrics
RC952-954.6
spellingShingle AIM
dopamine
6-hydroxydopamine
L-DOPA
LID
GRK6
GPCR
dyskinesia
nigra
Geriatrics
RC952-954.6
Wu N
Song L
Yang X
Yuan W
Liu Z
NMDA receptor regulation of levodopa-induced behavior and changes in striatal G protein-coupled receptor kinase 6 and ß-arrestin-1 expression in parkinsonian rats
description Na Wu, Lu Song, Xinxin Yang, Weien Yuan, Zhenguo Liu Department of Neurology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China Background: Parkinson’s disease is a neurodegenerative disorder caused by loss of dopaminergic neurons in the substantia nigra. The dopamine precursor, levodopa, remains the most effective and common treatment for this disorder. However, long-term administration of levodopa is known to induce characteristic dyskinesia, and molecular mechanisms underlying dyskinesia are poorly understood. Methods: In this study, we investigated the effect of 6-hydroxydopamine lesions in dopaminergic neurons and chronic treatment with levodopa on expression of G protein-coupled receptor kinase 6 and ß-arrestin-1, two key regulators of G protein-coupled receptors, in the rat striatum. Results: We found that a unilateral 6-hydroxydopamine lesion reduced expression of G protein-coupled receptor kinase 6 and ß-arrestin-1 protein in the lesioned striatum. Reduction of these two proteins persisted in 6-hydroxydopamine-lesioned rats on chronic levodopa treatment for 23 days. In addition, coadministration of the N-methyl-D-aspartate receptor antagonist, MK-801, and levodopa reversed the reduction of G protein-coupled receptor kinase 6 and ß-arrestin-1 in the striatum. MK-801 also attenuated levodopa-induced dyskinetic behavior. Conclusion: These data indicate that G protein-coupled receptor kinase 6 and ß-arrestin-1 in striatal neurons are sensitive to dopamine depletion and are downregulated in rats with Parkinson’s disease and in levodopa-treated rats with the disease. This downregulation seems to require activation of N-methyl-D-aspartate glutamate receptors. Keywords: dopamine, levodopa, levodopa-induced dyskinesias, G protein-coupled receptors, G protein-coupled receptor kinase dyskinesia
format article
author Wu N
Song L
Yang X
Yuan W
Liu Z
author_facet Wu N
Song L
Yang X
Yuan W
Liu Z
author_sort Wu N
title NMDA receptor regulation of levodopa-induced behavior and changes in striatal G protein-coupled receptor kinase 6 and ß-arrestin-1 expression in parkinsonian rats
title_short NMDA receptor regulation of levodopa-induced behavior and changes in striatal G protein-coupled receptor kinase 6 and ß-arrestin-1 expression in parkinsonian rats
title_full NMDA receptor regulation of levodopa-induced behavior and changes in striatal G protein-coupled receptor kinase 6 and ß-arrestin-1 expression in parkinsonian rats
title_fullStr NMDA receptor regulation of levodopa-induced behavior and changes in striatal G protein-coupled receptor kinase 6 and ß-arrestin-1 expression in parkinsonian rats
title_full_unstemmed NMDA receptor regulation of levodopa-induced behavior and changes in striatal G protein-coupled receptor kinase 6 and ß-arrestin-1 expression in parkinsonian rats
title_sort nmda receptor regulation of levodopa-induced behavior and changes in striatal g protein-coupled receptor kinase 6 and ß-arrestin-1 expression in parkinsonian rats
publisher Dove Medical Press
publishDate 2013
url https://doaj.org/article/d603fff1d73e4a34942f355af17d38d8
work_keys_str_mv AT wun nmdareceptorregulationoflevodopainducedbehaviorandchangesinstriatalgproteincoupledreceptorkinase6andszligarrestin1expressioninparkinsonianrats
AT songl nmdareceptorregulationoflevodopainducedbehaviorandchangesinstriatalgproteincoupledreceptorkinase6andszligarrestin1expressioninparkinsonianrats
AT yangx nmdareceptorregulationoflevodopainducedbehaviorandchangesinstriatalgproteincoupledreceptorkinase6andszligarrestin1expressioninparkinsonianrats
AT yuanw nmdareceptorregulationoflevodopainducedbehaviorandchangesinstriatalgproteincoupledreceptorkinase6andszligarrestin1expressioninparkinsonianrats
AT liuz nmdareceptorregulationoflevodopainducedbehaviorandchangesinstriatalgproteincoupledreceptorkinase6andszligarrestin1expressioninparkinsonianrats
_version_ 1718398393529663488

Ejemplares similares